Menu
Washingtoner
  • Home
  • Financial
  • Technology
  • Non-profit
  • Boeing
  • Business
  • Services
  • Education
  • Aerospace
Washingtoner

Iohexol Injection of Beilu Pharmaceutical Receives MA in the EU
Washingtoner/10288907

Trending...
  • Independent Financial Agencies Upgrade City of Tacoma's Bond Ratings Amid Broader Economic Uncertainty
  • Spokane: City Council Adopts "Immigration Enforcement Free Zones" Ordinance
  • Spokane: Indian Canyon Golf Course Opens Thursday, March 12, 2026
Iohexol Injection Of Beilu Pharma Receives MA Beijing Beilu Pharmaceutical Co., Ltd.
MIYUN, China - Washingtoner -- Recently, Beijing Beilu Pharmaceutical Co., Ltd. received the "Marketing Authorization" (MA) issued by the Netherlands Medicines Evaluation Board (MEB) in accordance with the relevant regulations of the European Medicines Agency.

Certificate information:
  • Company name: Beijing Beilu pharmaceutical Co., Ltd.
  • Manufacturing address: No.3 Shuiyuan West Road, Miyun District, Beijing, China
  • Registration number: RVG 132878
  • Drug name: Iohexol injection 350mg(I)/ml
  • Issuing authority: Netherlands Medicines Evaluation Board (MEB)
The successful registration of Iohexol Injection in Netherland indicates that the product has undergone rigorous scientific evaluation by EMA, confirming its compliance with EU Good Manufacturing Practice (GMP), quality, safety and efficacy standards. This authorization enables commercial distribution in EU-approved countries. It creates conditions for speeding up the Mutual recognition procedures(MRP) among EU countries such as Germany, France, Italy and others as well. This will help Beilu Pharmaceutical further promote the expansion of its overseas market and enhance the international market competitiveness of its contrast agent products, which is expected to have a positive impact on the company's operations in the future.

More on Washingtoner
  • Raleigh Emerges as a Key Player in Sustainable Fashion Innovation for 2026
  • Notice: Hrm Queen Laurence I Assumes Crown Control & $317q Fund. 3bn Unopoly Shares Settled. Requisition Of Buckingham Palace & Windsor Castle Final
  • 13 Full Moons of Black Dandelion Convergent Voice™ An Integration of Literacy & Wellness Symposium
  • Yoga Retreats, Ecstatic Dance & Spiritual App launched
  • Elder Abuse Case Against Healthy Traditions Owner Raises Questions As To The Dire Reality Of Abuse Against The Last Of The Baby Boomers

Contact Information:
Beijing Beilu Pharmaceutical Co., Ltd.
https://www.beilupharma.com/
yanglm@beilupharma.com

Contact
Beijing Beilu Pharmaceutical Co., Ltd. 
***@beilupharma.com


Source: Beijing Beilu Pharmaceutical Co., Ltd. 

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • The GUBERMAN Anomaly: Boeing's Alliance with ANSI–ANAB Exposed in Federal Contract 19AQMM18R0131
  • Danholm Collection Launches Boutique Luxury Real Estate Brokerage in Central Florida
  • Sellvia Market Expands Curated Store Portfolio for Dropshipping Sellers
  • Food Journal Magazine Raises the Standard for Restaurant Reviews in Los Angeles
  • StaffReady Expands Its Clinical Workforce Platform with ScheduleReady Compliance and Scheduling Suite
  • Williamsville Spa Expands Team to Meet Growing Demand for Professional Facials
  • PNW Virtual Health Announces Grand Opening of New Downtown Seattle Clinic
  • Pregis Expands Wind Energy Use, Advancing Progress Toward Net Zero by 2040
  • Dr. Sheel Desai Solomon and Preston Dermatology Continue Awards Streak with Top Honors in 2026 Maggy Awards
  • How Boeing's 2002 Mandates, ANAB's Federal Underwriter Fraud, and the 2026 GLOBAC Merger Exposed a Collapse in Certification Across All Industries
  • Jack and Sage Acquires Sustainable Apparel Brand Kastlfel, Expanding Premium Logo Wear Across National Parks and Ski Resorts
  • The Media Should Protect the Public When It Comes to Boeing — But Does It?
  • Cancun International Airport Prepares for Record Travel Surge Ahead of Spring Break, Summer, and the 2026 High Season
  • $167 Billion Pharma R&D Market Largely Untapped by AI Creates Major Growth Runway for KALA Bios Data-Sovereign AI Strategy: N A S D A Q: KALA
  • Lighthouse Tech Awards Recognize Top HR Technology Providers for 2026
  • ADB Selects OneVizion to Advance Field Execution and Infrastructure Program Management
  • Memelinked Social Media powered by cryptocurrency launching July 2026
  • Seven-Year-Old Toronto Dancer Julianna Selivanov Wins Nine Medals at Quebec Championship and Reaches Finals at UK Dance Festival
  • Independent Financial Agencies Upgrade City of Tacoma's Bond Ratings Amid Broader Economic Uncertainty
  • City of Spokane Partners with North Hill Christian Church, Jewels Helping Hands to Open New Scattered Site Shelter
_catLbl0 _catLbl1

Popular on Washingtoner

  • OneVizion Announces Next Phase of Growth as Brad Kitchens Joins Board of Directors - 151
  • Still Using Ice? FrostSkin Reinvents Hydration - 109
  • Male In Custody After North Spokane Drive By Shooting
  • Spokane: 2026 Safe Streets For All (Traffic Calming) Updates
  • Cold. Clean. Anywhere. Meet FrostSkin
  • Ice Melts. Infrastructure Fails. What Happens to Clean Water?
  • Spokane: Water Wise Wednesday Workshops Begin March 4
  • Tacoma City Council Announces City Manager Finalists
  • Primeindexer Google indexing platform launched by SEO Danmark APS
  • Tacoma: Applicants Sought for the Public Utility Board

Similar on Washingtoner

  • Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA
  • Phoenix Rebellion Therapy Celebrates 10 Years Helping Utahns Overcome Trauma as Utah Faces Nation's 2nd-Highest Rate of Mental Health Challenges
  • Yoga Retreats, Ecstatic Dance & Spiritual App launched
  • PNW Virtual Health Announces Grand Opening of New Downtown Seattle Clinic
  • Dr. Sheel Desai Solomon and Preston Dermatology Continue Awards Streak with Top Honors in 2026 Maggy Awards
  • $167 Billion Pharma R&D Market Largely Untapped by AI Creates Major Growth Runway for KALA Bios Data-Sovereign AI Strategy: N A S D A Q: KALA
  • Progressive Dental & The Closing Institute Partner with Zest Dental Solutions to Elevate Full-Arch Growth and Patient Outcomes
  • National Expansion Ignited Across Amazon $AMZN, Chewy $CHWY & Walmart $WMT: NDT Pharmaceuticals, Inc. (Stock Symbol: NDTP) $NDTP
  • Tarrytown Expocare Pharmacy Announces Strategic Leadership Appointments to Accelerate Growth and Innovation
  • NaturismRE Launches the NRE Health Institute to Advance Evidence-Informed Public Health Research
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute